3rd Quarter - Report
POLSINELLI PC for CEMPRA PHARMACEUTICALS
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare policies involving antibiotics to treat resistant pathogens
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM PERRIN | — |
| JULIE E SHROYER | — |
| HARRY ANASTASIOS SPORIDIS | — |
| RACHEL STEVENSON | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Budget/Appropriations BUD
Public Law No: 114-223, H.R. 5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act H.R. 5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 Combating Antibiotic-Resistant Bacteria
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM PERRIN | — |
| JULIE E SHROYER | — |
| HARRY ANASTASIOS SPORIDIS | — |
| RACHEL STEVENSON | — |
| STEVEN STRANNE | — |
| ALAN WHEAT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.